Xtant Medical Holdings, Inc. (XTNT)
NYSEAMERICAN: XTNT · Real-Time Price · USD
0.4702
+0.0142 (3.11%)
At close: Apr 8, 2026, 4:00 PM EDT
0.4800
+0.0098 (2.08%)
After-hours: Apr 8, 2026, 6:50 PM EDT

Xtant Medical Holdings Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
4.97-16.450.66-8.49-4.85
Depreciation & Amortization
5.224.223.171.291.33
Stock-Based Compensation
2.894.122.742.462.21
Other Adjustments
2.51.56-12.452.20.95
Change in Receivables
-0.59-0.76-8.74-3.94-0.32
Changes in Inventories
-2-2.49-1.89-1.152.62
Changes in Accounts Payable
-3.121.032.980.88-0.33
Changes in Accrued Expenses
4.2-2.923.791.15-1.11
Changes in Other Operating Activities
-1.54-0.220.220.26-0.07
Operating Cash Flow
12.55-11.9-9.52-5.340.44
Capital Expenditures
-2.38-4.11-1.46-1.76-2.12
Sale of Property, Plant & Equipment
0.230.380.180.210.23
Payments for Business Acquisitions
---23.5--
Proceeds from Business Divestments
10.05----
Investing Cash Flow
7.9-3.73-24.78-1.56-1.89
Short-Term Debt Issued
100.07112.6478.2254.2336.36
Short-Term Debt Repaid
-101.33-105.14-76.98-54.47-36.49
Net Short-Term Debt Issued (Repaid)
-1.267.51.24-0.24-0.13
Long-Term Debt Issued
-55--
Long-Term Debt Repaid
-8----0.41
Net Long-Term Debt Issued (Repaid)
-855--0.41
Issuance of Common Stock
-0.074.4714.019.3118.43
Repurchase of Common Stock
-0.13-0.18-0.26--0.2
Net Common Stock Issued (Repurchased)
-0.194.2913.759.3118.23
Other Financing Activities
-0.12-0.72-0.3-0.05-0.19
Financing Cash Flow
-9.5716.0719.699.0217.5
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.23-0.150.02--
Net Cash Flow
11.110.3-14.582.1216.05
Free Cash Flow
10.16-16.01-10.97-7.11-1.68
FCF Margin
7.59%-13.65%-12.02%-12.26%-3.03%
Free Cash Flow Per Share
0.07-0.12-0.09-0.08-0.02
Levered Free Cash Flow
-3.9-8.4313.72-8.07-5.06
Unlevered Free Cash Flow
9.78-16.42-19.96-6.04-3.53
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q